首页> 美国卫生研究院文献>other >Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus–related hepatocellular carcinoma
【2h】

Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus–related hepatocellular carcinoma

机译:遗传在sTaT4和HLa-DQ基因变异胙乙肝病毒相关性肝癌的风险

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To identify genetic susceptibility loci for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) in the Chinese population, we carried out a genome-wide association study (GWAS) in 2,514 chronic HBV carriers (1,161 HCC cases and 1,353 controls) followed by a 2-stage validation among 6 independent populations of chronic HBV carriers (4,319 cases and 4,966 controls). The joint analyses showed that HCC risk was significantly associated with two independent loci: rs7574865 at STAT4, Pmeta = 2.48 × 10−10, odds ratio (OR) = 1.21; and rs9275319 at HLA-DQ, Pmeta = 2.72 × 10−17, OR = 1.49. The risk allele G at rs7574865 was significantly associated with lower mRNA levels of STAT4 in both the HCC tissues and nontumor tissues of 155 individuals with HBV-related HCC (Ptrend = 0.0008 and 0.0002, respectively). We also found significantly lower mRNA expression of STAT4 in HCC tumor tissues compared with paired adjacent nontumor tissues (P = 2.33 × 10−14).
机译:为了确定中国人群中乙型肝炎病毒(HBV)相关的肝细胞癌(HCC)的遗传易感基因座,我们在2,514例慢性HBV携带者中进行了全基因组关联研究(GWAS)(1,161例HCC病例和1,353例对照),随后进行通过在6个独立的慢性HBV携带者人群中进行的2阶段验证(4,319例病例和4,966例对照)。联合分析显示,HCC风险与两个独立基因座显着相关:STAT4处的rs7574865,Pmeta = 2.48×10 -10 ,优势比(OR)= 1.21;和HLA-DQ处的rs9275319,Pmeta = 2.72×10 −17 ,OR = 1.49。 rs7574865中的风险等位基因G与155例HBV相关性HCC患者的HCC组织和非肿瘤组织中STAT4的mRNA水平降低显着相关(分别为0.0008和0.0002)。我们还发现与配对的相邻非肿瘤组织相比,HCC肿瘤组织中STAT4的mRNA表达明显降低(P = 2.33×10 −14 )。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号